The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed, and consumed worldwide.
USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are used in more than 140 countries.
USP’s focus on global public health extends to lower and middle-income countries with work in over 20 countries through donor-funded programs.
and 2) capacity-building activities to regulatory authorities to fulfill their function in ensuring the supply of quality-assured medical products.
The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, and dietary supplements manufactured, distributed, and consumed worldwide.
In Pakistan, Promoting the Quality of Medicines Plus (PQM+) Program is a Cooperative Agreement between the United States Agency for International Development (USAID) and USP.
This cooperative relationship supports the Drug Regulatory Authority of Pakistan (DRAP) for regulatory reforms, quality assurance systems, and strengthening the quality control laboratories in Pakistan.
Moreover, PQM+ also provides technical capacity building in close coordination with DRAP and provincial health authorities.
PQM+ plans to hire the services of a Pharmaceutical Policy and Quality Assurance consultant. The consultant should have extensive experience in the development of pharmaceutical policy.
The consultant will conduct analysis and oversee efforts to elevate the pharmaceutical policy and quality assurance agenda in Pakistan.
Consultant will play a lead role in driving the development of policy positions and strategies related to antimicrobial medicine quality.
This highly visible role requires extensive collaboration across government ministries, the Drug Regulatory Authority of Pakistan (DRAP), and pharmaceutical companies.
PERIOD OF PERFORMANCE
The scope of the work defined herein should be implemented before 30th September 2021. The assignment will be required 35 Working Days Level of Effort (LOE).
The selected individual will work in consultation with the USP Pakistan
Selected individuals will report to the PQM+ Chief of Party.
The Consultant is required to have the aforementioned professional and technical qualifications. Only the applicants who hold these qualifications will be shortlisted and contacted.
Please send CV / Profile, 3-References, and Daily Rate by downloading the following ANNEX D (Template) :
The Quoted Per Day Rate should be inclusive of all applicable taxes, traveling and any other associated costs.
Kindly send all Technical and Financial Proposals to ATTN : USP Pakistan Procurement at before the closing date (June 21
2021). When submitting your application, write "QA & Pharma Policy Consultant" in the email Subject Line.